End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
19.71 CNY | +0.87% |
|
+0.10% | -3.85% |
Capitalization | 39.01B 5.43B 4.65B 4.33B 4.04B 7.44B 466B 8.3B 52.55B 19.79B 219B 20.38B 19.96B 801B | P/E ratio 2025 * |
23x | P/E ratio 2026 * | 20.1x |
---|---|---|---|---|---|
Enterprise value | 34.8B 4.85B 4.15B 3.86B 3.6B 6.64B 416B 7.41B 46.88B 17.65B 195B 18.18B 17.8B 714B | EV / Sales 2025 * |
5.13x | EV / Sales 2026 * | 4.38x |
Free-Float |
46.44% | Yield 2025 * |
0.44% | Yield 2026 * | 0.59% |
More valuation ratios
* Estimated data
More news
1 day | +0.87% | ||
1 week | +0.10% | ||
Current month | +2.71% | ||
1 month | +2.02% | ||
3 months | -6.28% | ||
6 months | +2.92% | ||
Current year | -3.85% |
1 week | 19.46 | ![]() | 19.96 |
1 month | 18.88 | ![]() | 20.21 |
Current year | 18.88 | ![]() | 23.61 |
1 year | 18.88 | ![]() | 27.6 |
3 years | 16.11 | ![]() | 27.6 |
5 years | 12.44 | ![]() | 37.15 |
10 years | 6.53 | ![]() | 37.15 |
Manager | Title | Age | Since |
---|---|---|---|
Bo Tian
IRC | Investor Relations Contact | - | 2006-02-28 |
Xiang Ci
SEC | Corporate Secretary | 46 | 2002-12-31 |
Yi Zhang
DFI | Director of Finance/CFO | 55 | 2017-04-25 |
Director | Title | Age | Since |
---|---|---|---|
Hui Chuan Yang
CHM | Chairman | 58 | 2022-12-04 |
Li Gang Hu
BRD | Director/Board Member | 51 | 2017-05-24 |
Jing Jin Zhu
CHM | Chairman | 63 | 2016-10-31 |
Name | Weight | AuM | 1st Jan change | |
---|---|---|---|---|
0.66% | 0 M€ | -19.71% | - |
Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
---|---|---|---|---|---|---|
+0.87% | +0.10% | -20.01% | +12.36% | 5.43B | ||
+0.38% | +2.47% | -19.36% | -16.27% | 78.4B | ||
-0.01% | -0.84% | -49.96% | -9.81% | 57.9B | ||
+0.19% | +3.30% | +25.36% | +26.44% | 53.09B | ||
+2.15% | +0.41% | +22.47% | +104.51% | 37.64B | ||
+0.75% | -3.43% | -42.91% | -40.80% | 18.82B | ||
+3.36% | +11.03% | +116.52% | +146.47% | 18.77B | ||
+3.62% | +14.76% | +78.02% | +797.23% | 18.75B | ||
-0.04% | -.--% | +67.84% | +138.68% | 14.02B | ||
+1.44% | +0.74% | +8.17% | -13.49% | 13.4B | ||
Average | +1.10% | +0.74% | +18.62% | +114.53% | 31.62B | |
Weighted average by Cap. | +0.94% | +0.22% | +4.99% | +70.38% |
2025 * | 2026 * | |
---|---|---|
Net sales | 6.78B 944M 809M 753M 702M 1.29B 81.03B 1.44B 9.13B 3.44B 38.01B 3.54B 3.47B 139B | 7.65B 1.07B 912M 849M 792M 1.46B 91.41B 1.63B 10.3B 3.88B 42.87B 4B 3.91B 157B |
Net income | 1.72B 240M 205M 191M 178M 328M 20.58B 366M 2.32B 874M 9.65B 899M 881M 35.34B | 1.96B 273M 234M 217M 203M 373M 23.4B 417M 2.64B 993M 10.97B 1.02B 1B 40.18B |
Net Debt | -4.21B -587M -502M -468M -436M -803M -50.34B -897M -5.67B -2.14B -23.61B -2.2B -2.15B -86.46B | -5.47B -762M -653M -608M -566M -1.04B -65.41B -1.16B -7.37B -2.78B -30.68B -2.86B -2.8B -112B |
More financial data
* Estimated data
Employees
5,298
Sector
Pharmaceuticals
Calendar
Aug. 27
- Q2 2025 Earnings Release
Date | Price | Change | Volume |
---|---|---|---|
25-07-16 | 19.71 ¥ | +0.87% | 10,567,480 |
25-07-15 | 19.54 ¥ | -1.41% | 12,634,220 |
25-07-14 | 19.82 ¥ | +0.81% | 16,487,880 |
25-07-11 | 19.66 ¥ | -0.20% | 12,941,180 |
25-07-10 | 19.70 ¥ | +0.05% | 10,340,320 |
End-of-day quote Shanghai S.E., July 15, 2025
More quotesSell
Buy

Mean consensus
BUY
Number of Analysts
7
Last Close Price
19.71CNY
Average target price
28.00CNY
Spread / Average Target
+42.06%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- 600161 Stock
Select your edition
All financial news and data tailored to specific country editions